Application of 2-cyano-10- (2-methyl-3- (methylamino)- propyl) phenothiazine or a pharmaceutically acceptable salt as medicament
AssigneeAventis Pharmaceuticals Inc.
InventorsMichel Dib, Ahcene Hameg
Life of this patent
Estimating the term…
Abstract
The present invention relates to the application of 2-cyano-10-(2-methyl-3-(methylamino)-propyl)phenothiazine or a pharmaceutically acceptable salt thereof to produce a medicament intended for the treatment of sleep disorders, anxiety disorders, mood disorders, mixed anxiety-depression disorder, acute and chronic psychotic state, addiction to and withdrawal from a substance, extrapyramidal events induced by antipsychotics, or symptomatic dimensions during acute or chronic psychotic states as monotherapy or in combination with other antipsychotics.
Claims20
A method of treating a patient for sleep disorders comprising administering to said patient a therapeutically effective amount of 2-cyano-10-(2-methyl-3-(methylamino)propyl)phenothiazine (I) or a pharmaceutically acceptable salt thereof.
A method of treating a patient suffering from a disease selected from the group consisting of anxiety disorder, mood disorder, mixed anxiety-depression disorder, acute and chronic psychotic state, addiction to and withdrawal from a substance, extrapyramidal event induced by an antipsychotic and a symptomatic dimension during acute or chronic psychotic state, comprising administering to said patient a therapeutically effective amount of 2-cyano-10-(2-methyl-3-(methylamino)propyl)phenothiazine (I) or a pharmaceutically acceptable salt thereof.
A method for preparing a medicament comprising mixing a therapeutically effective amount of 2-cyano-10-(2-methyl-3-(methylamino)-propyl)phenothiazine or a pharmaceutically acceptable salt thereof with one or more compatible and pharmaceutically acceptable diluents or adjuvants.
Dependencies are inferred from the claim text.